Diabetes News

  • Characteristics of severe hypoglycemia identified in T2DM
    (HealthDay)—For patients with type 2 diabetes, characteristics of those with severe hypoglycemia include having a prior diagnosis of non-severe hypoglycemia and hemoglobin A1c (HbA1c) Read more »
  • Diabetes during pregnancy may increase baby's heart disease risk
    Gestational diabetes may increase the risk of blood vessel dysfunction and heart disease in offspring by altering a smooth muscle protein responsible for blood vessel network formation. Understanding of the protein's function in fetal cells may improve early detection of disease in children. The study is published ahead of print in the American Journal of Physiology—Cell Physiology. Read more »
  • Diabetes increases the risk of cancer, with a higher risk in women
    Diabetes is a risk factor for all-site cancer for both men and women, but the increased risk is higher in women than in men, according to a new article in Diabetologia (the journal of the European Association for the Study of Diabetes). Read more »
  • Switching to certain antidiabetic drugs linked to increased risk of major complications
    For people with type 2 diabetes, switching to sulfonylurea drugs to control blood sugar levels is associated with an increased risk of complications compared with staying on the drug metformin, finds a study in The BMJ today. Read more »
  • Basal insulin analogues similar for glucose lowering
    (HealthDay)—Basal insulin analogues for type 2 diabetes mellitus (T2DM) do not substantially differ in their glucose-lowering effect, according to a review published online July 10 in the Annals of Internal Medicine. Read more »
  • Evidence of clinical inertia in management of T2DM
    (HealthDay)—Many patients with type 2 diabetes (T2D) who have a hemoglobin A1c (HbA1c) level expected to trigger treatment intensification often have treatment inappropriately delayed, according to a research letter published in the July issue of Diabetes Care. Read more »
  • Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes
    For Hodalis Gaytan, 20, living with Type 1 diabetes means depending on an assortment of expensive medicines and devices to stay healthy. Test strips. Needles. A glucose meter. Insulin. Read more »
  • Diabetes drug with better side-effect tolerance could improve treatment
    Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week by researchers at the University of Pennsylvania and Syracuse University. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs. Read more »
  • PM2.5 contributes to burden of diabetes mellitus globally
    (HealthDay)—Particulate matter (PM) with a diameter of less than 2.5 micrograms per cubic meter of air (PM2.5) makes a substantial contribution to the burden of diabetes, according to a study published in the July issue of The Lancet Planetary Health. Read more »
  • A 3-pronged plan to cut type 2 diabetes risk
    (HealthDay)—The type 2 diabetes tide remains unchecked in the United States, as does pre-diabetes—having a blood sugar level higher than normal, but not high enough for a diabetes diagnosis. Read more »
  • Two regimens fail to stop declines in β-cell function
    (HealthDay)—Neither glargine followed by metformin nor metformin alone halts the progressive deterioration of β-cell function in youth with impaired glucose tolerance (IGT) or recently-diagnosed type 2 diabetes, according to a study published online June 25 in Diabetes Care. Read more »
  • Weight loss can protect overweight boys from developing type 2 diabetes
    A new study shows that overweight seven year olds have a higher risk of developing type 2 diabetes as adults, but only if they are still overweight by the time they hit puberty and beyond. Read more »
  • High prevalence of restrictive lung disease in people with type 2 diabetes
    Breathlessness and conditions of restrictive lung disease (RLD), such as pulmonary fibrosis, may be a late complication of type 2 diabetes. These are the key findings of a joint study undertaken by researchers from the German Center for Diabetes Research (DZD) and the German Center for Lung Research (DZL) under the leadership of the University Hospital Heidelberg. The latest results have been published in the journal Respiration. Read more »
  • New clinical trial to explore effects of omega-3 fatty acids and vitamin D in type 1 diabetes
    Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine today announced the launch of a new clinical trial that will assess the impact of high-dose omega-3 fatty acids and vitamin D supplementation on halting the progression of type 1 diabetes (T1D). The DRI has received FDA IND clearance to proceed with the Phase I/IIa trial, named the POSEIDON Study (Pilot study of Omega-3 and Vitamin D High Doses in T1D), to compare the effects of the proposed intervention in children and adults newly diagnosed and in those with longer-standing T1D to evaluate any benefit of early and late interventions. Read more »
  • Circadian system, misalignment have distinct impact on insulin
    (HealthDay)—The endogenous circadian system, behavioral cycle, and circadian misalignment have distinct effects on insulin sensitivity and β-cell function, according to a study published online June 4 in Diabetes, Obesity and Metabolism. Read more »
  • Type 2 diabetes—is it what you eat, or how much?
    Type 2 diabetes is a growing concern. Already, two million Australians and almost half a billion people worldwide have diabetes. Read more »
  • Programs can lower diabetes distress in adults with T1DM
    (HealthDay)—Both education/behavioral and emotion-focused approaches can effectively reduce diabetes distress (DD) among patients with type 1 diabetes (T1D) and elevated hemoglobin A1c (HbA1c), according to a study published online July 5 in Diabetes Care. Read more »
  • Physician views of self-monitoring blood glucose in patients not on insulin
    Physicians continue to recommend routine self-monitoring of blood glucose for patients with non-insulin treated type 2 diabetes, in spite of its lack of effectiveness, because they believe it drives the lifestyle change needed to improve glycemic control. Read more »
  • New technology for early detection of type 1 diabetes
    Researchers are developing early detection technology for Type 1 diabetes that can accurately predict if a child is at risk of the chronic disease. Read more »
  • Researchers cure type 2 diabetes and obesity in mice using gene therapy
    A research team from the UAB led by Professor Fatima Bosch has managed to cure obesity and type 2 diabetes in mice using gene therapy. Read more »
Pin It